Jorge Conde – Biographie

Jorge était Chief Strategy Officer, Chief Financial Officer and Chief Product Officer chez Syros Pharmaceuticals, et Co-Founder, Chief Executive Officer and Director chez Knome. Jorge Conde a rejoint Andreessen Horowitz en 2017.

Jorge Conde est actuellement

• General Partner, Lead of Biology, Computer Science and Engineering Investments at Andreessen Horowitz - View - Andreessen Horowitz org chart

• Director at Asimov - View - Asimov org chart

• Director at Cartography Biosciences - View - Cartography Biosciences org chart

• Director at Dyno Therapeutics - View - Dyno Therapeutics org chart

• Director at IDRx - View - IDRx org chart

• Director at Octant - View - Octant org chart

• Director at Tome Biosciences - View - Tome Biosciences org chart

• Director at Vicinitas Therapeutics - View - Vicinitas Therapeutics org chart

Créer une alerte
pour suivre le parcours de Jorge Conde.

Jorge Conde a obtenu un Master of Science in Biomedical Enterprise de Harvard-MIT Division of Health Sciences and Technology et un Master of Business Administration de Harvard Business School.

Ils ont aussi étudié à Harvard Business School:

• Andrew Wexler - Herschend Enterprises
• Douglas Herrington - Amazon
• Jeffrey Teper - Microsoft

Trouver d'autres anciens étudiants de Harvard Business School

Voici quelques conseils pour établir rapidement un excellent contact.